written on 17.06.2014

Immuno-Oncology is the Word as ASCO Abstracts went Public


Even before the American Society of Clinical Oncology (ASCO) freed thousands of abstracts from embargo, immunotherapy already was emerging as the biggest story at the meeting in Chicago and big pharma firms as its major stars. Since being highlighted at last year’s ASCO meeting and being named Science magazine’s Breakthrough of the Year for 2013, […]